pillbase.ru

ANGIOTENSIN II

Active substance: angiotensin II

INJECTION · ANGIOTENSIN II 2.5 mg/mL

United StatesActive

Marketing holder: Gland Pharma Limited

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Giapreza
    angiotensin II acetate
    EMEA/H/C/004930
    Paion Pharma GmbH
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-a73e-7222-8e08-1856baa48843,01a12090-9577-7f97-96f3-d42de1ef5f54,01a1209b-ab43-72ea-9b8b-3cbfca92ce10;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
68083-553
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 68083-553 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 68083-553 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 68083-553 · Verified 2026-10-09 · open in source